Sirolimus for the Treatment of Airway Obstruction due to Indolent T-Lymphoblastic Proliferation.


Journal

Case reports in immunology
ISSN: 2090-6609
Titre abrégé: Case Reports Immunol
Pays: Egypt
ID NLM: 101622188

Informations de publication

Date de publication:
2019
Historique:
received: 27 05 2019
revised: 01 10 2019
accepted: 17 10 2019
entrez: 25 1 2020
pubmed: 25 1 2020
medline: 25 1 2020
Statut: epublish

Résumé

Indolent T-lymphoblastic proliferation (iT-LBP) is a rare nonmalignant entity that presents as a proliferation of T-lymphoblasts. We report a first such case with a recurrent laryngeal obstruction presentation that was successfully controlled with Sirolimus. This is the case of a 29-year-old female who presented with a recurrent significant lymphoid hyperplasia in the adenoid and tongue base region as well as a right cervical lymph node. After repeated adenoidectomies and tonsillectomies, and based on pathological and clinical findings she was diagnosed with iT-LBP. Trials of radiotherapy and immunotherapy with cyclosporine and rituximab all failed to control the progression of the disease. Sirolimus was finally able to restrict the growth and improve her symptoms. While It-LBP does not usually require treatment, it is important to report cases in which treatment was crucial for the survival of the patient, and the effective role of Sirolimus in doing so, without any major adverse effects.

Identifiants

pubmed: 31976096
doi: 10.1155/2019/1724083
pmc: PMC6959153
doi:

Types de publication

Case Reports

Langues

eng

Pagination

1724083

Informations de copyright

Copyright © 2019 Eric Moughames et al.

Déclaration de conflit d'intérêts

The authors declare no potential conflicts of interest.

Références

J Pathol Transl Med. 2015 Jan;49(1):1-4
pubmed: 25812651
Am J Surg Pathol. 2001 Mar;25(3):411-5
pubmed: 11224614
Int J Clin Exp Pathol. 2014 Aug 15;7(9):6350-6
pubmed: 25337290
Am J Surg Pathol. 1999 Aug;23(8):977-81
pubmed: 10435569
Br J Haematol. 2017 Jun;177(5):684-702
pubmed: 28146265
Immunopharmacology. 2000 May;47(2-3):119-25
pubmed: 10878286
Am J Surg Pathol. 2014 Sep;38(9):1298-304
pubmed: 24618611
Hum Pathol. 2015 Nov;46(11):1785-6
pubmed: 26363525
Adv Anat Pathol. 2013 May;20(3):137-40
pubmed: 23574769
Histopathology. 2018 Apr;72(5):862-866
pubmed: 29143359

Auteurs

Eric Moughames (E)

Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Ana P Kiess (AP)

Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Lee M Akst (LM)

Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Antoine Azar (A)

Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Classifications MeSH